State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, and University of Chinese Academy of Sciences , Shanghai 200032, China.
Acc Chem Res. 2018 Feb 20;51(2):507-516. doi: 10.1021/acs.accounts.7b00573. Epub 2018 Jan 3.
Naturally occurring glycans and glycoconjugates have extremely diverse structures and biological functions. Syntheses of these molecules and their artificial mimics, which have attracted the interest of those developing new therapeutic agents, rely on glycosylation methodologies to construct the various glycosidic linkages. In this regard, a wide array of glycosylation methods have been developed, and they mainly involve the substitution of a leaving group on the anomeric carbon of a glycosyl donor with an acceptor (a nucleophile) under the action of a particular promoter (usually a stoichiometric electrophile). However, glycosylations involving inherently unstable or unreactive donors/acceptors are still problematic. In those systems, reactions involving nucleophilic, electrophilic, or acidic species present on the leaving group and the promoter could become competitive and detrimental to the glycosylation. To address this problem, we applied the recently developed chemistry of alkynophilic gold(I) catalysts to the development of new glycosylation reactions that would avoid the use of the conventional leaving groups and promoters. Gratifyingly, glycosyl o-alkynylbenzoates (namely, glycosyl o-hexynyl- and o-cyclopropylethynylbenzoates) turned out to be privileged donors under gold(I) catalysis with PhPAuNTf and PhPAuOTf. The merits of this new glycosylation protocol include the following: (1) the donors are easily prepared and are generally shelf-stable; (2) the promotion is catalytic; (3) the substrate scope is extremely wide; (4) relatively few side reactions are observed; (5) the glycosylation conditions are orthogonal to those of conventional methods; and (6) the method is operationally simple. Indeed, this method has been successfully applied in the synthesis of a wide variety of complex glycans and glycoconjugates, including complex glycosides of epoxides, nucleobases, flavonoids, lignans, steroids, triterpenes, and peptides. The direct glycosylation of some sensitive aglycones, such as dammarane C20-ol and sugar oximes, and the glycosylation-initiated polymerization of tetrahydrofuran were achieved for the first time. The gold(I) catalytic cycle of the present glycosylation protocol has been fully elucidated. In particular, key intermediates, such as the 1-glycosyloxyisochromenylium-4-gold(I) and isochromen-4-ylgold(I) complexes, have been unambiguously characterized. Exploiting the former glycosyloxypyrylium intermediate, S2-type glycosylations were realized in specific cases, such as β-mannosylation/rhamnosylation. The protodeauration of the latter vinylgold(I) intermediate has been reported to be critically important for the gold(I) catalytic cycle. Thus, the addition of a strong acid as a cocatalyst can dramatically reduce the required loading of the gold(I) catalyst (down to 0.001 equiv). C-Glycosylation with silyl nucleophiles can proceed catalytically when moisture, which is sequestered by molecular sieves, can serve as the H donor for the required protodeauration step. Indeed, the unique mechanism explains the merits and broad applicability of the present glycosylation method and provides a foundation for future developments in glycosylation methodologies that mainly involve improving the diastereoselectivity and catalytic efficiency of glycosylations.
天然存在的糖和糖缀合物具有极其多样的结构和生物学功能。这些分子及其人工模拟物的合成引起了开发新治疗剂的人的兴趣,它们依赖于糖基化方法来构建各种糖苷键。在这方面,已经开发出了广泛的糖基化方法,它们主要涉及在糖苷供体的端基碳原子上用受体(亲核试剂)取代离去基团,在特定的促进剂(通常是化学计量的亲电试剂)的作用下。然而,涉及固有不稳定或反应性供体/受体的糖基化仍然是一个问题。在这些系统中,涉及离去基团和促进剂上的亲核、亲电或酸性物种的反应可能变得具有竞争性,并对糖基化产生不利影响。为了解决这个问题,我们将最近开发的亲金(I)催化剂化学应用于开发新的糖基化反应,这些反应将避免使用传统的离去基团和促进剂。令人高兴的是,在 PhPAuNTf 和 PhPAuOTf 的催化下,糖基邻炔基苯甲酸酯(即糖基邻己炔基和邻环丙基乙炔基苯甲酸酯)成为金(I)催化下的有利供体。这种新的糖基化方案的优点包括以下几点:(1)供体易于制备,通常稳定;(2)促进是催化性的;(3)底物范围极广;(4)观察到的副反应较少;(5)糖基化条件与传统方法正交;(6)操作简单。事实上,这种方法已成功应用于各种复杂糖和糖缀合物的合成,包括环氧化物、碱基、类黄酮、木脂素、甾体、三萜和肽的复杂糖苷。首次实现了一些敏感糖苷配基如达玛烷 C20-醇和糖肟的直接糖基化,以及四氢呋喃的糖基化引发聚合。本糖基化方案的金(I)催化循环已得到充分阐明。特别是,已经明确表征了关键中间体,如 1-糖氧基异苯并吡喃-4-金(I)和异苯并-4-金(I)配合物。利用前糖苷氧基吡喃鎓中间体,在某些情况下实现了 S2 型糖基化,例如β-甘露糖基化/鼠李糖基化。后者的乙烯基金(I)中间体的脱金反应对于金(I)催化循环至关重要。因此,添加强酸作为共催化剂可以显著降低金(I)催化剂的所需负载量(低至 0.001 当量)。当可以用分子筛捕获的水分作为所需脱金步骤的 H 供体时,硅基亲核试剂的 C-糖基化可以进行催化。事实上,独特的机制解释了本糖基化方法的优点和广泛适用性,并为主要涉及提高糖基化的非对映选择性和催化效率的糖基化方法的未来发展提供了基础。